Navigation Links
AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate
Date:12/15/2009

WASHINGTON, Dec. 15 /PRNewswire-USNewswire/ -- Today's New York Times article by Kevin Sack, "Plan for Kidney Drugs Spurs Division," illustrates an internal renal community reimbursement debate that may result in kidney patients continuing to be deprived of their life-saving immunosuppressive medications beyond the current 36-month Medicare program limit.

As Congress is poised to approve this urgent transplant patient coverage to preserve the lives of transplant kidney recipients, behind-the-scenes debate continues within the renal community regarding how dialysis should be reimbursed. The American Society of Transplantation (AST) believes strongly that dialysis reimbursement, while important, should not hold hostage a bill that would provide thousands of kidney transplant patients their desperately needed and life-saving immunosuppressant medications.

AST President, Dr. Joren Madsen, stated this morning, "I applaud the New York Times for drawing attention to an urgent patient care issue which should not fall victim to politics as usual." Transplant patient immunosuppressive drug coverage has been AST's #1 Public Policy Issue for more than a decade. As this morning's New York Times article states, "It is pound foolish" to pay for a patient's organ transplant and then only give them a 36-month supply of the drugs they need to maintain their life-saving donor organ for the remainder of their life.

About AST

The American Society of Transplantation is an international organization of transplant professionals dedicated to advancing the field of transplantation through the promotion of research, education, advocacy, and organ donation to improve patient care. The Society comprises more than 3,100 transplant physicians, surgeons and allied health professionals.

For information about AST, visit www.a-s-t.org.


    CONTACT: Beth Drost at 215.884.6499
    beth@comsolutionsgroup.com

SOURCE The American Society of Transplantation


'/>"/>
SOURCE The American Society of Transplantation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ACC Concerned Over Reporting of Biomonitoring Results
2. Methodist Dallas Medical Center First in Metroplex to Perform Kidney Transplant on HIV Positive Patient
3. FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems
4. Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases
5. FDA Approves New Treatment for Advanced Form of Kidney Cancer
6. Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz, CA
7. Study Suggests that NGAL Identifies Acute Kidney Injury Early in ICU Patients
8. Bayers Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
9. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
10. WORLDS First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
11. Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning and Tacrolimus Monotherapy: Long-Term Safety and Efficacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with ... Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
Breaking Medicine News(10 mins):